Yeah that appears to be a great purchase. RGS is out of favour at the moment but I love the look of their existing products and product pipeline. Sales growth was impressive and they will now be focusing more on marketing in this area of the business as they have realised they probably can't continue to tap the market for funds.
Funding human trials will be costly so I hope they plan this well and make use of funds.
A true growth potential though. Wouldn't surprise me to see this around 40-50c within 12 months.
RGS Price at posting:
12.0¢ Sentiment: Hold Disclosure: Held
